*.*

Source link : https://www.newshealth.biz/health-news/topical-treatment-effective-for-young-kids-up-to-52-weeks/

Treatment with topical ruxolitinib cream 1.5% showed good tolerability and was effective over the course of 52 weeks in children aged 2-11 years with atopic dermatitis (AD) affecting ≥ 35% or more of their body surface area (BSA), results from a small open-label maximum-use trial showed. “Safe and effective treatments are needed for children with […]

Author : News Health

Publish date : 2024-06-17 06:57:06

Copyright for syndicated content belongs to the linked Source.

........
....................................................................................................